Litcius/Paper detail

Phase II INTEGRIS-PSC trial of bexotegrast, an αvβ6/αvβ1 integrin inhibitor, in primary sclerosing cholangitis

Gideon M. Hirschfield, Kris V. Kowdley, Palak Trivedi, Bertus Eksteen, Bilal Hameed, Catherine Vincent, Tianyan Chen, Aparna Goel, K. Gautham Reddy, Eric S. Orman, Deepak Joshi, Éric Lefebvre, Johanna Schaub, Mahru C. An, Annie Clark, Chris N. Barnes, Richard Pencek, Douglas Thorburn, Aldo J. Montaño‐Loza, Christoph Schramm, Christopher L. Bowlus, Michael Trauner, Cynthia Levy

2025Journal of Hepatology7 citationsDOI

Topics & Concepts

Primary sclerosing cholangitisMedicineIntegrinPathologyCancer researchPhase (matter)GastroenterologyPrimary (astronomy)Biliary tractPhases of clinical researchInternal medicineLiver Diseases and ImmunityInflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies
Phase II INTEGRIS-PSC trial of bexotegrast, an αvβ6/αvβ1 integrin inhibitor, in primary sclerosing cholangitis | Litcius